Sort
15,842 grants matching “pancreatic cancer”
Humanized Anti-Trop2-SN-38 Conjugate For Advanced Pancreatic Cancer
$227,025William A. Wegener · Immunomedics, Inc. · R43 · FY2012 · CA
New molecular target and its inhibitors for use against pancreatic cancer
$226,935Duxin Sun · University Of Michigan At Ann Arbor · R21 · FY2010 · CA
Structural Basis for Synergistic Gene Expression by Runx1 and Ets1 Proteins
$226,931Tahir H Tahirov · University Of Nebraska Medical Center · R01 · FY2009 · GM
Regulation of Food Intake and Body Adiposity by Peptide YY
$226,922Roger Reidelberger · Creighton University · R01 · FY2010 · DK
TFG-Beta Isoform Signaling in Pancreatic Development
$226,879Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2003 · DK
TFG-Beta Isoform Signaling in Pancreatic Development
$226,879Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2004 · DK
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$226,873Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2024 · CA
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$226,844Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
GENETICALLY OPTIMIZED IMMUNOTOXINS FOR LEUKEMIA THERAPY
$226,829University Of Minnesota Twin Cities · R01 · FY2001 · CA
IDO2 Targeting for pancreatic cancer treatment
$226,695George C Prendergast · Lankenau Institute For Medical Research · R21 · FY2011 · CA
Cellular Interactions between TGF-B Pathway Members and TERT and c-Myc in Gastroi
$226,406Bibhuti B Mishra · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Selective inhibition of COPZ1 in PDAC cells
$226,325Roberto Gomes · North Dakota State University · P20 · FY2023 · GM
Mesenchymal Stem Cell-Based Targeted Combined Therapy for Pancreatic Ductal Adenocarcinoma
$226,317Buddhadev Layek · North Dakota State University · P20 · FY2023 · GM
Core A: Pathology Core
$226,306Anirban Maitra · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
X-ray studies of metalloenzyme regulation and catalysis
$226,230Massachusetts Institute Of Technology · R01 · FY2003 · GM
Core B: Human Pancreas
$226,204Walter Gwang-Up Park · Stanford University · P01 · FY2025 · CA
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
$225,979Despina Siolas · New York University School Of Medicine · K08 · FY2020 · CA
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
$225,979Despina Siolas · Weill Medical Coll Of Cornell Univ · K08 · FY2021 · CA
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
$225,979Despina Siolas · New York University School Of Medicine · K08 · FY2019 · CA
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
$225,979Despina Siolas · Weill Medical Coll Of Cornell Univ · K08 · FY2023 · CA
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
$225,979Despina Siolas · Weill Medical Coll Of Cornell Univ · K08 · FY2022 · CA
Administrative Core
$225,964Alison P Klein · Johns Hopkins University · P50 · FY2022 · CA
Administrative Core
$225,964Alison P Klein · Johns Hopkins University · P50 · FY2019 · CA
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor
$225,955Timothy Yen · Research Inst Of Fox Chase Can Ctr · R21 · FY2014 · CA
An integrated system for tumor detection and targeted drug therapy of cancer
$225,862Duxin Sun · University Of Michigan At Ann Arbor · R01 · FY2008 · CA